FDA-approved PDE4 inhibitors reduce the dominant toxicity of ALS–FTD-associated CHCHD10S59L
Preprint in bioRxiv (June 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Preprint in bioRxiv (June 2024)
Article in Molecules (April 2024)
Article in Anesthesia & Analgesia (December 2023)